{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T10:20:46Z","timestamp":1698574846497},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":723,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Studies have shown that 1\u2010week triple therapy consisting of a proton pump inhibitor, amoxycillin and clarithromycin may cure <jats:italic>Helicobacter pylori<\/jats:italic> infection in the majority of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To establish whether pantoprazole plus amoxycillin in association with either azithromycin or clarithromycin is useful in curing <jats:italic>H.\u2003pylori<\/jats:italic> infection in patients with a duodenal ulcer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>One hundred and ten patients with active duodenal ulcers and <jats:italic>H.\u2003pylori<\/jats:italic> infection were treated with pantoprazole (days 1\u20137, 40\u2003mg b.d.; days 8\u201328 40\u2003mg o.d.) plus amoxycillin 1\u2003g b.d. for the first 7\u2003days. Patients were randomly assigned to receive either azithromycin 500\u2003mg o.d. for the first 6\u2003days (PAAz group; <jats:italic>n<\/jats:italic>=55) or clarithromycin 500\u2003mg b.d. for the first 7\u2003days of treatment (PAC group; <jats:italic>n<\/jats:italic>=55). <jats:italic>H.\u2003pylori<\/jats:italic> status was determined by urease test and histology before the treatment, and again 4\u2003weeks after cessation of any medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>One hundred and three patients completed the study. <jats:italic>H.\u2003pylori<\/jats:italic> infection was eradicated in 78% (39\/50) of patients in the PAAz group (ITT analysis: 71%, 95% CI: 61\u201383%) vs. 81% (43\/53) of patients in the PAC group (ITT analysis: 78%, 95% CI: 69\u201390%) (N.S.). All ulcers had healed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Our study shows that 1\u2010week triple therapy with pantoprazole, amoxycillin and either azithromycin or clarithromycin is not satisfactory (&lt;80% ITT <jats:italic>H.\u2003pylori<\/jats:italic> eradication rate).<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00662.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:06Z","timestamp":1047354006000},"page":"69-72","source":"Crossref","is-referenced-by-count":13,"title":["Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of <i>Helicobacter pylori<\/i> in duodenal ulcer"],"prefix":"10.1111","volume":"14","author":[{"family":"V\u010dev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"\u0160timac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ivandi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"V\u010deva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Taka\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Pezerovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00303.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-9-705"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005771"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094856"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_9_2","first-page":"A1","article-title":"Low\u2010dose triple therapy for eradication of Helicobacter pylori: a large multicentre, randomised trial","volume":"38","author":"Misiewicz JJ","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.727119000.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00462.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"e_1_2_6_13_2","first-page":"258","article-title":"Triple therapy with azithromycin, omeprazole and amoxicillin is highly effective in eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin","volume":"91","author":"Bertoni G","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00332.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.1999.09041.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.d01-533.x"},{"key":"e_1_2_6_17_2","first-page":"A35","article-title":"Randomised study comparing two seven day triple therapies with lansoprazole and low dose of clarithromycin plus amoxycillin or tinidazole for H.\u2003pylori eradication","volume":"39","author":"Lamouliatte H","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.130301000.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00662.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00662.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00662.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:49:22Z","timestamp":1695883762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00662.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00662.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00662.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}